A novel in vivo model to study bacterial pathogenesis and screen potential therapeutic targets

References

1. Achtman M., Mercer A., Kusecek B., Pohl A., Heuzenroeder M., Aaronson W., Sutton A., Silver R. P. 1983; Six widespread bacterial clones among Escherichia coli K1 isolates. Infect Immun 39:315–335[PubMed]
   [Google Scholar]
2. Alarcon A., Peña P., Salas S., Sancha M., Omeñaca F. 2004; Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis. Pediatr Infect Dis J 23:295–299 [View Article][PubMed]
   [Google Scholar]
3. Andrä J., Berninghausen O., Leippe M. 2001; Cecropins, antibacterial peptides from insects and mammals, are potently fungicidal against Candida albicans . Med Microbiol Immunol (Berl) 189:169–173 [View Article][PubMed]
   [Google Scholar]
4. Bonacorsi S., Bingen E. 2005; Molecular epidemiology of Escherichia coli causing neonatal meningitis. Int J Med Microbiol 295:373–381 [View Article][PubMed]
   [Google Scholar]
5. Cociancich S., Bulet P., Hetru C., Hoffmann J. A. 1994; The inducible antibacterial peptides of insects. Parasitol Today 10:132–139 [View Article][PubMed]
   [Google Scholar]
6. de Louvois J., Blackbourn J., Hurley R., Harvey D. 1991; Infantile meningitis in England and Wales: a two year study. Arch Dis Child 66:603–607 [View Article][PubMed]
   [Google Scholar]
7. Gillard G. O., Bivas-Benita M., Hovav A. H., Grandpre L. E., Panas M. W., Seaman M. S., Haynes B. F., Letvin N. L. 2011; Thy1+ NK cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes. PLoS Pathog 7:e1002141 [View Article][PubMed]
   [Google Scholar]
8. Gladstone I. M., Ehrenkranz R. A., Edberg S. C., Baltimore R. S. 1990; A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J 9:819–890 [View Article][PubMed]
   [Google Scholar]
9. Goldsworthy G., Mullen L., Opoku-Ware K., Chandrakant S. 2003; Interactions between the endocrine and immune systems in locusts. Physiol Entomol 28:54–61 [View Article]
   [Google Scholar]
10. Hoffmann J. A., Hoffmann D. 1990; The inducible antibacterial peptides of dipteran insects. Res Immunol 141:910–918[PubMed] [CrossRef]
    [Google Scholar]
11. Khan N. A., Goldsworthy G. J. 2007; Novel model to study virulence determinants of Escherichia coli K1. Infect Immun 75:5735–5739 [View Article][PubMed]
    [Google Scholar]
12. Khan N. A., Siddiqui R. 2009; Acanthamoeba affects the integrity of human brain microvascular endothelial cells and degrades the tight junction proteins. Int J Parasitol 39:1611–1616 [View Article][PubMed]
    [Google Scholar]
13. Kim K. S. 2003; Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci 4:376–385 [View Article][PubMed]
    [Google Scholar]
14. Kurtz J. 2005; Specific memory within innate immune systems. Trends Immunol 26:186–192 [View Article][PubMed]
    [Google Scholar]
15. Mokri-Moayyed B., Goldsworthy G. J., Khan N. A. 2008; Development of a novel ex vivo insect model for studying virulence determinants of Escherichia coli K1. J Med Microbiol 57:106–110 [View Article][PubMed]
    [Google Scholar]
16. Otvos L. Jr 2000; Antibacterial peptides isolated from insects. J Pept Sci 6:497–511 [View Article][PubMed]
    [Google Scholar]
17. Steiner H., Andreu D., Merrifield R. B. 1988; Binding and action of cecropin and cecropin analogues: antibacterial peptides from insects. Biochim Biophys Acta 939:260–266 [View Article][PubMed]
    [Google Scholar]